CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850862255
- Phone
- 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $709,240
- in 1 filing, $709K under 10b5-1 plans
Net −$709,240. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-02 | Hung David President and CEO | Other disposition | −368,408 | 58,281,054 | ||
| 2021-02-10 | Sharp Shalini Director | Option exercise | +25,000 | 25,000 | ||
| 2021-02-10 | Sharp Shalini Director | Grant or award | +10,000 | $10.00 | $100K | 35,000 |
| 2021-02-10 | Sharp Shalini Director | Option exercise · Class B Common Stock | −25,000 | 0 | ||
| 2021-02-10 | BRADBURY DANIEL Director | Option exercise | +25,000 | 25,000 | ||
| 2021-02-10 | BRADBURY DANIEL Director | Option exercise · Class B Common Stock | −25,000 | 0 | ||
| 2021-02-10 | Hasnain Faheem Director | Option exercise | +25,000 | 25,000 | ||
| 2021-02-10 | Hasnain Faheem Director | Grant or award | +30,000 | $10.00 | $300K | 55,000 |
| 2021-02-10 | Hasnain Faheem Director | Option exercise · Class B Common Stock | −25,000 | 0 | ||
| 2021-02-10 | COOPER GRAHAM K Director | Option exercise | +25,000 | 25,000 | ||
| 2021-02-10 | COOPER GRAHAM K Director | Option exercise · Class B Common Stock | −25,000 | 0 | ||
| 2021-02-10 | NODELMAN OLEG Director | Conversion | +2,775,000 | 3,165,000 | ||
| 2021-02-10 | NODELMAN OLEG Director | Grant or award | +2,106,000 | 2,106,000 | ||
| 2021-02-10 | NODELMAN OLEG Director | Grant or award | +394,000 | 394,000 | ||
| 2021-02-10 | NODELMAN OLEG Director | Grant or award | +2,112,735 | $10.00 | $21.1M | 4,218,735 |
| 2021-02-10 | NODELMAN OLEG Director | Grant or award | +387,265 | $10.00 | $3.9M | 781,265 |
| 2021-02-10 | NODELMAN OLEG Director | Grant or award | +2,365,511 | 6,584,246 | ||
| 2021-02-10 | NODELMAN OLEG Director | Grant or award | +515,879 | 1,297,144 | ||
| 2021-02-10 | NODELMAN OLEG Director | Grant or award | +2,200,627 | 2,200,627 | ||
| 2021-02-10 | NODELMAN OLEG Director | Conversion · Class B Common Stock | −2,775,000 | 0 |
Page 13 of 15 · 291 trades